Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody
Authors:
- Paul J. KostenuikPKPaul J. Kostenuik
- Susan Y. SmithSSSusan Y. Smith
- Jacquelin JoletteJJJacquelin Jolette
- Joseph SchroederJSJoseph Schroeder
- Ian PyrahIPIan Pyrah
- Michael S. OminskyMOMichael S. Ominsky
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Lasofoxifene in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2010
- Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With OsteoporosisJournal of Bone and Mineral Research, 2009
- Co-Treatment of PTH With Osteoprotegerin or Alendronate Increases Its Anabolic Effect on the Skeleton of Oophorectomized MiceJournal of Bone and Mineral Research, 2007
- Change in Bone Turnover and Hip, Non-Spine, and Vertebral Fracture in Alendronate-Treated Women: The Fracture Intervention TrialJournal of Bone and Mineral Research, 2004
- Relationship Between Changes in Biochemical Markers of Bone Turnover and BMD to Predict Vertebral Fracture RiskJournal of Bone and Mineral Research, 2004
- Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With RisedronateJournal of Bone and Mineral Research, 2003
- Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeysBone, 2003
- Effect of Risedronate on the Risk of Hip Fracture in Elderly WomenNew England Journal of Medicine, 2001
- Fracture Risk Reduction with Alendronate in Women with Osteoporosis: The Fracture Intervention TrialThe Journal of Clinical Endocrinology & Metabolism, 2000
- Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective studyJournal of Bone and Mineral Research, 1996